Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy

PURPOSE: To evaluate costs and cost-utility of early vitrectomy (pars plana vitrectomy [PPV]) compared with panretinal photocoagulation (PRP) and intravitreal ranibizumab (IVR) for proliferative diabetic retinopathy (PDR) without diabetic macular edema. DESIGN: A decision analysis model of cost-util...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ophthalmology
Päätekijät: Lin, James, Chang, Jonathan S., Yannuzzi, Nicolas A., Smiddy, William E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6941652/
https://ncbi.nlm.nih.gov/pubmed/29606379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2018.02.038
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia